BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 36225140)

  • 1. HIV awareness and prevention strategies among transgender women in the Eastern and Southern United States: findings from the LITE Study.
    Aguayo-Romero RA; Cannon CM; Wirtz AL; Cooney EE; Mayer KH; Reisner SL;
    J Int AIDS Soc; 2022 Oct; 25 Suppl 5(Suppl 5):e25999. PubMed ID: 36225140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating HIV pre-exposure prophylaxis and harm reduction among men who have sex with men and transgender women to address intersecting harms associated with stimulant use: a modelling study.
    Bórquez A; Rich K; Farrell M; Degenhardt L; McKetin R; Tran LT; Cepeda J; Silva-Santisteban A; Konda K; Cáceres CF; Kelly S; Altice FL; Martin NK
    J Int AIDS Soc; 2020 Jun; 23 Suppl 1(Suppl 1):e25495. PubMed ID: 32562365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services.
    Liu AY; Cohen SE; Vittinghoff E; Anderson PL; Doblecki-Lewis S; Bacon O; Chege W; Postle BS; Matheson T; Amico KR; Liegler T; Rawlings MK; Trainor N; Blue RW; Estrada Y; Coleman ME; Cardenas G; Feaster DJ; Grant R; Philip SS; Elion R; Buchbinder S; Kolber MA
    JAMA Intern Med; 2016 Jan; 176(1):75-84. PubMed ID: 26571482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a pre-exposure prophylaxis programme for men who have sex with men and transgender women in Thailand: learning through the HIV prevention cascade lens.
    Ramautarsing RA; Meksena R; Sungsing T; Chinbunchorn T; Sangprasert T; Fungfoosri O; Meekrua D; Sumalu S; Pasansai T; Bunainso W; Wongsri T; Mainoy N; Colby D; Avery M; Mills S; Vannakit R; Phanuphak P; Phanuphak N
    J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25540. PubMed ID: 32602660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demand creation and retention strategies for oral pre-exposure prophylaxis for HIV prevention among men who have sex with men and transgender women: a systematic review and meta-analysis.
    Guimarães NS; Magno L; Monteiro GMB; Ramos ICN; de Castro CT; Aranha-Rossi TR; Pereira M; Dourado I
    BMC Infect Dis; 2023 Nov; 23(1):793. PubMed ID: 37964202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal strategies to improve uptake of and adherence to HIV prevention among young people at risk for HIV acquisition in the USA (ATN 149): a randomised, controlled, factorial trial.
    Swendeman D; Rotheram-Borus MJ; Arnold EM; Fernández MI; Comulada WS; Lee SJ; Ocasio MA; Ishimoto K; Gertsch W; Duan N; Reback CJ; Murphy DA; Lewis KA;
    Lancet Digit Health; 2024 Mar; 6(3):e187-e200. PubMed ID: 38395539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring Contextual Differences for Sexual Role Strain Among Transgender Women and Men Who Have Sex with Men in Lima, Peru.
    Satcher MF; Segura ER; Silva-Santisteban A; Reisner SL; Perez-Brumer A; Lama JR; Operario D; Clark JL
    Arch Sex Behav; 2022 May; 51(4):1977-1991. PubMed ID: 35290540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Use of HIV Pre- and Postexposure Prophylaxis Among a Web-Based Sample of HIV-Negative and Unknown Status Cisgender and Transgender Sexual Minority Men: Cross-sectional Study.
    John SA; Sizemore KM; Jimenez RH; Jones SS; Petroll AE; Rendina HJ
    JMIR Public Health Surveill; 2022 Dec; 8(12):e31237. PubMed ID: 36306518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with long-term HIV pre-exposure prophylaxis engagement and adherence among transgender women in Brazil, Mexico and Peru: results from the ImPrEP study.
    Konda KA; Torres TS; Mariño G; Ramos A; Moreira RI; Leite IC; Cunha M; Jalil EM; Hoagland B; Guanira JV; Benedetti M; Pimenta C; Vermandere H; Bautista-Arredondo S; Vega-Ramirez H; Veloso VG; Caceres CF; Grinsztejn B;
    J Int AIDS Soc; 2022 Oct; 25 Suppl 5(Suppl 5):e25974. PubMed ID: 36225148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV prevalence and incidence in a cohort of South African men and transgender women who have sex with men: the Sibanye Methods for Prevention Packages Programme (MP3) project.
    Sullivan PS; Phaswana-Mafuya N; Baral SD; Valencia R; Zahn R; Dominguez K; Yah CS; Jones J; Kgatitswe LB; McNaghten AD; Siegler AJ; Sanchez TH; Bekker LG
    J Int AIDS Soc; 2020 Oct; 23 Suppl 6(Suppl 6):e25591. PubMed ID: 33000918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.
    Grinsztejn B; Hoagland B; Moreira RI; Kallas EG; Madruga JV; Goulart S; Leite IC; Freitas L; Martins LMS; Torres TS; Vasconcelos R; De Boni RB; Anderson PL; Liu A; Luz PM; Veloso VG;
    Lancet HIV; 2018 Mar; 5(3):e136-e145. PubMed ID: 29467098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention-effective adherence trajectories among transgender women indicated for PrEP in the United States: a prospective cohort study.
    Cooney EE; Reisner SL; Saleem HT; Althoff KN; Beckham SW; Radix A; Cannon CM; Schneider JS; Haw JS; Rodriguez AE; Wawrzyniak AJ; Poteat TC; Mayer KH; Beyrer C; Wirtz AL;
    Ann Epidemiol; 2022 Jun; 70():23-31. PubMed ID: 35398255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sexually transmitted infections incidence in young Thai men who have sex with men and transgender women using HIV pre-exposure prophylaxis.
    Songtaweesin WN; Pornpaisalsakul K; Kawichai S; Wacharachaisurapol N; Wongharn P; Yodkitudomying C; Panichnantakul P; Theerawit T; Pankam T; Puthanakit T
    Int J STD AIDS; 2022 Apr; 33(5):447-455. PubMed ID: 35282719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.
    Hoornenborg E; Coyer L; Achterbergh RCA; Matser A; Schim van der Loeff MF; Boyd A; van Duijnhoven YTHP; Bruisten S; Oostvogel P; Davidovich U; Hogewoning A; Prins M; de Vries HJC;
    Lancet HIV; 2019 Jul; 6(7):e447-e455. PubMed ID: 31178284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-exposure prophylaxis for transgender women and men who have sex with men: qualitative insights from healthcare providers, community organization-based leadership and end users in coastal Kenya.
    Kimani M; Sanders EJ; Chirro O; Mukuria N; Mahmoud S; Rinke de Wit TF; Graham SM; Operario D; van der Elst EM
    Int Health; 2022 May; 14(3):288-294. PubMed ID: 34325469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PrEP initiation and discontinuation among transgender women in the United States: a longitudinal, mixed methods cohort study.
    Cooney EE; Saleem HT; Stevenson M; Aguayo-Romero RA; Althoff KN; Poteat TC; Beckham SW; Adams D; Radix AE; Wawrzyniak AJ; Cannon CM; Schneider JS; Haw JS; Rodriguez AE; Mayer KH; Beyrer C; Reisner SL; Wirtz AL;
    J Int AIDS Soc; 2023 Dec; 26(12):e26199. PubMed ID: 38123897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dismantling Barriers and Transforming the Future of Pre-Exposure Prophylaxis Uptake in Young Black and Latinx Sexual Minority Men and Transgender Women.
    Shorrock F; Alvarenga A; Hailey-Fair K; Vickroy W; Cos T; Kwait J; Trexler C; Wirtz AL; Galai N; Beyrer C; Celentano D; Arrington-Sanders R
    AIDS Patient Care STDS; 2022 May; 36(5):194-203. PubMed ID: 35507322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
    Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
    AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engagement in the pre-exposure prophylaxis (PrEP) cascade among a respondent-driven sample of sexually active men who have sex with men and transgender women during early PrEP implementation in Zimbabwe.
    Parmley LE; Harris TG; Chingombe I; Mapingure M; Mugurungi O; Rogers JH; Gozhora P; Wu Y; Samba C; Musuka G; Hakim AJ
    J Int AIDS Soc; 2022 Feb; 25(2):e25873. PubMed ID: 35148029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Willingness to use and preferences for long-acting injectable PrEP among sexual and gender minority populations in the southern United States, 2021-2022: cross-sectional study.
    Schoenberg P; Edwards OW; Merrill L; Martinez CA; Stephenson R; Sullivan PS; Jones J
    J Int AIDS Soc; 2023 Mar; 26(3):e26077. PubMed ID: 36951057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.